Clinical Trials Browser

INDUSTRY × Carcinoma, Transitional Cell × rocakinogene sifuplasmid × Clear all

NCT03502785 2025-07-10

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Phase 1/2 Completed

Carcinoma, Transitional Cell